Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6601
Heritage Global
HGBL
$43.3M
| $22.6K | ﹤0.01% |
18,668
| – | – |
2025 Q1
5 quarters
|
|
6602
iShares iBonds 1-5 Year Corporate Ladder ETF
LDRC
$94.3M
| $22.5K | ﹤0.01% |
895
| – | – |
2025 Q4
2 quarters
|
|
6603
Nine Energy Service Inc
NINE
$108M
| $22.5K | ﹤0.01% |
1,726
+1,261
| +271% | +$12.8K |
2026 Q1
1 quarter
|
|
6604
Global X Infrastructure Development ex-U.S. ETF
IPAV
$5.12M
| $22.4K | ﹤0.01% |
698
-4,731
| -87% | -$157K |
2026 Q1
1 quarter
|
|
6605
Corgi Lithography & Semiconductor Photonics ETF
EUV
$469M
| $22.4K | ﹤0.01% |
+700
| New | +$19.6K |
2026 Q2
0 quarters
|
|
6606
FT Vest US Equity Deep Buffer ETF December
DDEC
$432M
| $22.4K | ﹤0.01% |
472
| – | – |
2023 Q1
13 quarters
|
|
6607
PetMed Express
PETS
$27.9M
| $22.3K | ﹤0.01% |
11,604
+224
| +2% | +$475 |
2013 Q2
52 quarters
|
|
6608
John Hancock Mortgage-Backed Securities ETF
JHMB
$211M
| $22.1K | ﹤0.01% |
1,009
| – | – |
2023 Q4
10 quarters
|
|
6609
Global X Aging Population ETF
AGNG
$88M
| $22K | ﹤0.01% |
611
| – | – |
2020 Q2
24 quarters
|
|
6610
Vanguard US Multifactor ETF
VFMF
$964M
| $22K | ﹤0.01% |
124
-1
| -0.8% | -$169 |
2022 Q4
14 quarters
|
|
6611
Teucrium Soybean Fund
SOYB
$45.4M
| $22K | ﹤0.01% |
900
+25
| +3% | +$615 |
2018 Q1
33 quarters
|
|
6612
QTREX Quantum
QTEX
$125M
| $21.9K | ﹤0.01% |
15,218
+11,838
| +350% | +$12.4K |
2025 Q3
3 quarters
|
|
6613
Defiance Daily Target 2x Long MSTR ETF
MSTX
$367M
| $21.9K | ﹤0.01% |
2,943
| – | – |
2024 Q3
7 quarters
|
|
6614
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.4B
| $21.8K | ﹤0.01% |
1,756
-104,549
| -98% | -$1.42M |
2023 Q3
11 quarters
|
|
6615
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$159M
| $21.8K | ﹤0.01% |
511
| – | – |
2024 Q2
8 quarters
|
|
6616
Astoria US Quality Growth Kings ETF
GQQQ
$178M
| $21.8K | ﹤0.01% |
600
| – | – |
2026 Q1
1 quarter
|
|
6617
ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038
UCIB
| $21.5K | ﹤0.01% |
661
| – | – |
2021 Q1
21 quarters
|
|
6618
Columbia Large Cap Growth ETF
REGS
$67.3M
| $21.5K | ﹤0.01% |
1,908
| – | – |
2026 Q1
1 quarter
|
|
6619
Zone Frontier Inc.
ZONE
$66.4M
| $21.5K | ﹤0.01% |
+26,187
| New | +$14.5K |
2026 Q2
0 quarters
|
|
6620
Artiva Biotherapeutics
ARTV
$339M
| $21.5K | ﹤0.01% |
2,212
-14,165
| -86% | -$129K |
2024 Q3
7 quarters
|
|
6621
Grace Therapeutics
GRCE
$43.8M
| $21.4K | ﹤0.01% |
9,448
+4,900
| +108% | +$13.6K |
2017 Q3
35 quarters
|
|
|
PTNM
6622
DELISTED
Pitanium Ltd
PTNM
| $21.4K | ﹤0.01% |
2,064
| – | – |
2025 Q3
3 quarters
|
|
6623
Federated Hermes US Strategic Dividend ETF
FDV
$909M
| $21.4K | ﹤0.01% |
683
-292
| -30% | -$9.12K |
2024 Q3
7 quarters
|
|
6624
Eloxx Pharmaceuticals
ELOX
$47.2M
| $21.4K | ﹤0.01% |
+1,544
| New | +$19.7K |
2026 Q2
0 quarters
|
|
6625
FT Vest Nasdaq-100 Conservative Buffer ETF - July
QCJL
$104M
| $21.4K | ﹤0.01% |
855
| – | – |
2024 Q3
7 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.